IDEAS home Printed from https://ideas.repec.org/p/ehl/lserod/103689.html
   My bibliography  Save this paper

Lobbying expenditures and campaign contributions by the pharmaceutical and health-product industry in the United States, 1999- 2018

Author

Listed:
  • Wouters, Olivier J.

Abstract

Importance: Government efforts to lower drug costs and other legislative and regulatory initiatives may be counteracted by campaign donors and lobbyists in the pharmaceutical and health product industry. Objective: To review how much money the pharmaceutical and health product industry spent on campaign contributions and lobbying in the US from 1999 to 2018 at the federal and state levels. Design and Setting: Analysis of federal-level and state-level data obtained from the Center for Responsive Politics and the National Institute on Money in Politics, respectively. These nonprofit, nonpartisan organizations track federal and state campaign contributions and lobbying expenditures by individuals and groups. Exposures: Lobbying expenditures and contributions to political campaigns. Main Outcomes and Measures: Total spending, inflation adjusted to 2018 dollars using the US Consumer Price Index, on lobbying and campaign contributions by year, source, and state. Results: From 1999 to 2018, the pharmaceutical and health product industry recorded $4.7 billion- A n average of $233 million per year-in lobbying expenditures at the federal level, more than any other industry. Of the spending, the trade group Pharmaceutical Research and Manufacturers of America accounted for $422 million (9.0%), and the other 19 top companies and organizations in this industry accounted for $2.2 billion (46.8%). The industry spent $414 million on contributions to candidates in presidential and congressional elections, national party committees, and outside spending groups. Of this amount, $22 million went to presidential candidates and $214 million went to congressional candidates. Of the 20 senators and 20 representatives who received the most contributions, 39 belonged to committees with jurisdiction over health-related legislative matters, 24 of them in senior positions. The industry contributed $877 million to state candidates and committees, of which $399 million (45.5%) went to recipients in California and $287 million (32.7%) went to recipients in 9 other states. In years in which key state referenda on reforms in drug pricing and regulation were being voted on, there were large spikes in contributions to groups that opposed or supported the reforms. Conclusions and Relevance: From 1999 to 2018, the pharmaceutical and health product industry spent large sums of money on lobbying and campaign contributions to influence legislative and election outcomes. These findings can inform discussions about how to temper the influence of industry on US health policy.

Suggested Citation

  • Wouters, Olivier J., 2020. "Lobbying expenditures and campaign contributions by the pharmaceutical and health-product industry in the United States, 1999- 2018," LSE Research Online Documents on Economics 103689, London School of Economics and Political Science, LSE Library.
  • Handle: RePEc:ehl:lserod:103689
    as

    Download full text from publisher

    File URL: http://eprints.lse.ac.uk/103689/
    File Function: Open access version.
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Gerber, Alan, 1998. "Estimating the Effect of Campaign Spending on Senate Election Outcomes Using Instrumental Variables," American Political Science Review, Cambridge University Press, vol. 92(2), pages 401-411, June.
    2. Joshua L. Kalla & David E. Broockman, 2016. "Campaign Contributions Facilitate Access to Congressional Officials: A Randomized Field Experiment," American Journal of Political Science, John Wiley & Sons, vol. 60(3), pages 545-558, July.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Van De Vrande, Vareska & Subramanian, Annapoornima M. & Lévesque, Moren & Klopf, Patricia, 2024. "The interdependent influence of lobbying and intellectual capital on new drug development," Research Policy, Elsevier, vol. 53(2).
    2. Gómez, Eduardo J., 2022. "Enhancing our understanding of the commercial determinants of health: Theories, methods, and insights from political science," Social Science & Medicine, Elsevier, vol. 301(C).
    3. Rice, Thomas & Barnes, Andrew J. & Rosenau, Pauline & Unruh, Lynn Y. & van Ginneken, Ewout, 2021. "Health reforms in the United States: The outlook after Biden's first 100 days," Health Policy, Elsevier, vol. 125(10), pages 1277-1284.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ching-Hsing Wang, 2022. "The Effect of Political Donation on Election Outcomes: Evidence from Taiwan Legislative Elections," SAGE Open, , vol. 12(1), pages 21582440221, March.
    2. Bruno Carvalho, 2021. "Campaign Spending in Local Elections: the Effects of Public Funding," Working Papers ECARES 2021-30, ULB -- Universite Libre de Bruxelles.
    3. Anne E. Baker, 2021. "Loan Financing as a Tool for Nonincumbent House Candidates," Social Science Quarterly, Southwestern Social Science Association, vol. 102(4), pages 1466-1483, July.
    4. Andrew Gelman & Guido Imbens, 2013. "Why ask Why? Forward Causal Inference and Reverse Causal Questions," NBER Working Papers 19614, National Bureau of Economic Research, Inc.
    5. Daniel Houser & Sandra Ludwig & Thomas Stratmann, 2009. "Does Deceptive Advertising Reduce Political Participation? Theory and Evidence," Working Papers 1011, George Mason University, Interdisciplinary Center for Economic Science.
    6. Julia Cage & Edgard Dewitte, 2021. "It Takes Money to Make MPs: Evidence from 150 Years of British Campaign Spending," SciencePo Working papers hal-03384143, HAL.
    7. Freille, Sebastián, 2015. "Do private campaing contributions affect electoral results? An examination of Argentine national elections," MPRA Paper 65455, University Library of Munich, Germany.
    8. Hao, Jinghui & Heerink, Nico & Heijman, Wim & Bijman, Jos, 2017. "Cooperatives Membership And Smallholder Farmers’ Welfare - Evidence From Shaanxi And Shandong Provinces, China," 2017 International Congress, August 28-September 1, 2017, Parma, Italy 260914, European Association of Agricultural Economists.
    9. Shaun M. Tanger & Richard Alan Seals Jr. & David N. Laband, 2011. "Does Bill Co-sponsorship Affect Campaign Contributions?: Evidence from the U.S. House of Representatives, 2000-2008," Auburn Economics Working Paper Series auwp2011-09, Department of Economics, Auburn University.
    10. Cécile Aubert & Huihui Ding, 2022. "Voter conformism and inefficient policies," Social Choice and Welfare, Springer;The Society for Social Choice and Welfare, vol. 59(1), pages 207-249, July.
    11. Andreas Peichl & Nico Pestel & Sebastian Siegloch, 2013. "The politicians’ wage gap: insights from German members of parliament," Public Choice, Springer, vol. 156(3), pages 653-676, September.
    12. Nathan Canen & Kristopher Ramsay, 2024. "Quantifying theory in politics: Identification, interpretation, and the role of structural methods," Journal of Theoretical Politics, , vol. 36(4), pages 301-327, October.
    13. Bryan Engelhardt & Justin Svec, 2012. "Political Contributions and Insurance," Working Papers 1204, College of the Holy Cross, Department of Economics.
    14. Fink, Alexander, 2012. "The effects of party campaign spending under proportional representation: Evidence from Germany," European Journal of Political Economy, Elsevier, vol. 28(4), pages 574-592.
    15. Thomas Stratmann, 2006. "Contribution limits and the effectiveness of campaign spending," Public Choice, Springer, vol. 129(3), pages 461-474, December.
    16. Greiner, Michael & Kim, Jaemin & Cordon Thor, Jennifer, 2023. "Narcissistic CEOs and their corporate political activity," Journal of Business Research, Elsevier, vol. 163(C).
    17. Thomas Bassetti & Filippo Pavesi, 2012. "Deep Pockets, Extreme Preferences: Interest Groups and Campaign Finance Contributions," Working Papers 222, University of Milano-Bicocca, Department of Economics, revised Apr 2012.
    18. Alan Gerber, 2004. "Does campaign spending work?," Natural Field Experiments 00246, The Field Experiments Website.
    19. Raphael Boleslavsky & Christopher Cotton, 2015. "Information and Extremism in Elections," American Economic Journal: Microeconomics, American Economic Association, vol. 7(1), pages 165-207, February.
    20. Balán, Pablo & Dodyk, Juan & Puente, Ignacio, 2022. "The political behavior of family firms: Evidence from Brazil," World Development, Elsevier, vol. 151(C).

    More about this item

    JEL classification:

    • R14 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General Regional Economics - - - Land Use Patterns
    • J01 - Labor and Demographic Economics - - General - - - Labor Economics: General

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ehl:lserod:103689. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: LSERO Manager (email available below). General contact details of provider: https://edirc.repec.org/data/lsepsuk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.